StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Galleri

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Jun 08, 2021 1:34pm

86 Views

Post# 33348568

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Galleri

All of the articles I have read on this board of the type you contributed never mention StageZero or Aristotle.

Are we the black sheep or long lost cousin of this cancer busting group?

I still have faith (in fact I increased my position by 110% since mid-May); but I would like some tangible income results - soon.

My main concern is that technology can move forward at a very rapid pace; we don't want to be by-passed by the next big breakthrough, and there will be one, probably sooner than later.

Cheers

<< Previous

Bullboard Posts

Next >>

The long-term forecast for lithium stocks in 2024